KMB vs CLX Comparison: AI Score, Valuation, Performance and Upside
Compare Kimberly-Clark's tissue and diaper brand portfolio against Clorox's cleaning, disinfecting, and household brand lineup.
Use this Kimberly-Clark vs Clorox comparison to evaluate the key differences across valuation, growth, profitability, and risk before making an investment decision.
KMB holds the edge across 5 of 5 key metrics in this comparison. KMB leads on both 1-year return (-18.00%) and forward P/E quality (14.63x vs 16.30x for CLX), a relatively favorable combination of momentum and valuation. KMB leads on both revenue growth (0.60%) and operating margin (19.00%), suggesting a stronger fundamental setup on both dimensions. Analyst consensus implies meaningfully more upside for KMB (+8.26%) than for CLX (-0.86%).
Human Wall Street analysts' price targets, typically implying a ~12-month view — a separate signal from this site's own AI Prediction Signal further down the page, which is a 5-/30-day machine-learning forecast based on price history alone.
| Metric | KMB | CLX |
|---|---|---|
| AI scorei | 40.0 | 26.5 |
| AI ranki | #1152 | #2571 |
| Latest closei | $104.96 | $93.06 |
| 1M returni | -6.59% | -12.07% |
| 6M returni | +0.05% | -18.15% |
| 1Y returni | -18.00% | -24.29% |
How much would $10,000 be worth today if invested at the start of each period, with all dividends reinvested?
| Period | KMB | CLX |
|---|---|---|
| 1Y ago | $8.13K (-18.7%) started 2025-09-04 | $7.47K (-25.3%) started 2025-09-04 |
| 5Y ago | $9.9K (-1.0%) started 2021-09-07 | $7.08K (-29.2%) started 2021-09-07 |
| 10Y ago | $15.35K (+53.5%) started 2016-09-06 | $11.88K (+18.8%) started 2016-09-06 |
Hypothetical — past performance does not guarantee future results.
| Metric | KMB | CLX |
|---|---|---|
| Market capi | $36.43B | $12.4B |
| Trailing P/Ei | 21.65 | 21.32 |
| Forward P/Ei | 14.63 | 16.30 |
| Price/Salesi | 2.24 | N/A |
| EV/Revenuei | 2.54 | 2.68 |
| Analyst targeti | $118.60 | $101.65 |
| Target upsidei | +8.26% | -0.86% |
| Metric | KMB | CLX |
|---|---|---|
| Revenue growthi | 0.60% | -2.00% |
| Earnings growthi | -32.30% | -50.10% |
| EPS growthi | -32.30% | -50.10% |
| FCF margini | +5.68% | +1.64% |
| Operating margini | 19.00% | 12.88% |
| Profit margini | 11.79% | 8.73% |
| ROIC proxyi | 104.91% | 163.76% |
| Return on equityi | 104.91% | 163.76% |
| Dividend yieldi | 4.67% | 4.88% |
| Betai | 0.28 | 0.54 |
| Debt/equityi | 348.93 | 2221.43 |
| Current ratioi | 0.91 | 0.66 |
| Quick ratioi | 0.40 | 0.34 |
Over the past year, KMB and CLX have moved moderately in the same direction (correlation of 0.55), based on daily returns.
Lower drawdown and smaller single-period drops generally indicate a smoother ride, though they do not guarantee lower future risk.
| Period | Metric | KMB | CLX |
|---|---|---|---|
| 1Y | Growthi | -18.74% | -25.33% |
| CAGRi | -18.77% | -25.36% | |
| Volatilityi | 27.14% | 30.78% | |
| Sharpe ratioi | -0.79 | -0.94 | |
| Sortino ratioi | -0.97 | -1.22 | |
| Max drawdowni | 28.95% | 32.27% | |
| Current drawdowni | 19.86% | 26.82% | |
| Avg drawdowni | 18.69% | 16.43% | |
| Ulcer Indexi | 19.87% | 18.45% | |
| Max daily dropi | 14.57% | 9.67% | |
| Max wkly dropi | 16.59% | 11.72% | |
| 5Y | Growthi | -14.17% | -37.59% |
| CAGRi | -3.02% | -9.01% | |
| Volatilityi | 20.78% | 26.48% | |
| Sharpe ratioi | -0.26 | -0.39 | |
| Sortino ratioi | -0.34 | -0.53 | |
| Max drawdowni | 36.87% | 48.43% | |
| Current drawdowni | 28.79% | 44.27% | |
| Avg drawdowni | 11.98% | 19.83% | |
| Ulcer Indexi | 15.28% | 22.88% | |
| Max daily dropi | 14.57% | 14.47% | |
| Max wkly dropi | 16.59% | 15.29% | |
| 10Y | Growthi | +9.08% | -9.88% |
| CAGRi | +0.87% | -1.04% | |
| Volatilityi | 21.35% | 24.98% | |
| Sharpe ratioi | -0.06 | -0.10 | |
| Sortino ratioi | -0.09 | -0.13 | |
| Max drawdowni | 36.87% | 58.23% | |
| Current drawdowni | 28.79% | 54.86% | |
| Avg drawdowni | 11.16% | 22.00% | |
| Ulcer Indexi | 13.65% | 27.02% | |
| Max daily dropi | 14.57% | 14.47% | |
| Max wkly dropi | 18.53% | 15.29% |
| Category | KMB | CLX |
|---|---|---|
| Company | KMB | CLX |
| Sector | Consumer Defensive | Consumer Defensive |
| Industry | Household & Personal Products | Household & Personal Products |
| Core business | Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care products in the United States. | The Clorox Company manufactures and markets consumer and professional products worldwide. |
Want deeper AI forecasts?
This comparison page is public and free forever. Subscribers can unlock saved watchlists, full AI rankings, detailed forecasts, and interactive analysis tools.
Full valuation workup with AI Score, Monte Carlo forecast, and bull/bear case — free preview, premium data from $3.99.